Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Iatrogenic hypertriglyceridemia]

G Turpin1, E Bruckert

  • 1Service d'Endocrinologie-Métabolisme, Groupe hospitalier Pitié-Salpêtrière, Paris.

Presse Medicale (Paris, France : 1983)
|June 25, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Hypercholesterolemia, from screening to treatment: Who, why and how to manage].

La Revue de medecine interne·2020
Same author

Psychological predictors of the combined adoption of physical exercise and dietary change among adults with hypercholesterolemia.

Revue d'epidemiologie et de sante publique·2018
Same author

Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
Same author

[Statin treatment must be personalized].

La Revue de medecine interne·2018
Same author

[Familial hypercholesterolemia: A largely underestimated cardiovascular risk].

Annales de cardiologie et d'angeiologie·2017
Same author

Consensus statement on the management of dyslipidaemias in adults.

Annales d'endocrinologie·2017
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Endogenous hypertriglyceridemia and drug-induced hypertriglyceridemia increase risks for atherosclerosis and thrombosis. Recognizing and managing these conditions is crucial for patient health.

Area of Science:

  • Endocrinology and Metabolism
  • Cardiovascular Medicine
  • Pharmacology

Context:

  • Endogenous hypertriglyceridemia (Type IV) is linked to atherosclerosis and thrombosis.
  • Drug-induced hypertriglyceridemia is a growing concern.
  • Pathophysiological mechanisms are under continuous investigation.

Purpose:

  • To highlight the pathogenic effects of endogenous and iatrogenic hypertriglyceridemia.
  • To identify common drug classes causing iatrogenic hypertriglyceridemia.
  • To emphasize the clinical importance of recognizing and managing these lipid abnormalities.

Summary:

  • Endogenous hypertriglyceridemia (Type IV) contributes to atherosclerosis and thrombosis.
  • Iatrogenic hypertriglyceridemia results from various medications including oral contraceptives, hormone replacement therapy, antihypertensives, corticosteroids, retinoids, cyclosporine, enzyme inducers, and iodine-induced hypothyroidism.

Related Experiment Videos

  • Management involves modifying or interrupting treatment when high lipid levels are detected.

    • Impact:

    • Increased awareness of drug-induced hypertriglyceridemia can prevent adverse cardiovascular events.
    • Prompt recognition and management of hypertriglyceridemia mitigate risks of atherosclerosis, thrombosis, and pancreatitis.
    • Understanding these mechanisms aids in refining treatment protocols for dyslipidemia.